Clinical Research Directory
Browse clinical research sites, groups, and studies.
Risk Factors and Long-term Impact of ICIs
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Summary
This study plans to conduct a multicenter, observable and controlled cohort study to solid-tumor patients with receiving immunotherapy and to collect information about their treatment related efficacy, adverse events and health status to build a disease cohort database based on patient reports, and then analyze the risk factors affecting the efficacy, prognosis and adverse events of immunotherapy and the impact of immunotherapy on health status. It is expected to provide high-level evidence-based medical evidence for the selection of immunotherapy schemes for these patients, the precise prevention and health management of adverse events after immunotherapy, and the further improvement of survival prognosis of patients
Official title: To Evaluate the Prognostic Risk Factors and Long-term Health Effects of Immunotherapy Patients Based on the Specific Disease Cohort Registered With Patients
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2022-11-24
Completion Date
2025-12-31
Last Updated
2025-02-07
Healthy Volunteers
Not specified
Conditions
Interventions
Solid tumor patients receiving immunotherapy for the first time were included in the study
Solid tumor patients receiving immunotherapy were included in the study. Baseline information before treatment (including demographic characteristics, basic diseases and their medication history, tumor and anti-tumor history, quality of life scores, etc.) and follow-up information after treatment (PFS, OS, etc.) were collected to summarize factors that may affect the efficacy and prognosis of patients receiving immunotherapy
Locations (1)
First Affiliated Hospitap of Xian Jiaotong University
Xi’an, Shanxi, China